Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to National Comprehensive Cancer Network
Related studies linked through entity extraction aliases.
Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Axitinib in Advanced Carcinoid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE1
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Selumetinib With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
- Status
- COMPLETED
- Phase
- PHASE2
Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine and Bevacizumab for Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM
- Status
- COMPLETED
- Phase
- PHASE1
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2